| |
|
|
| |
Patient Self-Monitoring
Devices, Markets, Players and Prospects
|
Publication: May 2011
Product Code: SPM919R
|
The ability of patients to monitor their own serum levels is
deemed to be a critical tool in reducing the pathological
effects of poorly controlled disease factors. For conditions
other than diabetes, the vast majority of monitoring has
until recently been performed in physician offices or
similar healthcare settings. The convergence of new
measurement technologies, patient demographics and managed
care cost initiatives is driving patient monitoring for a
number of conditions from caregiver facilities and into
homes. In the process, patient self-monitoring for
cholesterol, INR and hypertension have the potential to
transition from a cottage industry into a significant
market. The key enabler of this significant shift will be
technological advances that will provide accurate readings
in a format that consumers can understand, clearly
indicating when a follow-up visit to a caregiver is needed.
Systems that allow patients to share readings with
physicians electronically have already been introduced.
Ultimately, the success of this self-test market will rely
on monitors that can provide accurate values for the various
analytes that are associated with health risk, presenting
them to the patient in the proper context.. |
|
Highlights |
· Analyzes and evaluates
self-test monitoring technologies
and products, and assesses the market
potential, commercialization risks and opportunities
· Examines
next-generatione monitor technologies, design issues and evolving market
factors
· Provides forecasts and
market data for self-monitoring products to 2015
· Assesses the impact and
influence of self-monitoring enhancements on the
healthcare management market
· Profiles self-monitoring market
participants, their technology, product
development activity, and business
strategies
|
|
Summary of Contents |
Executive Summary
Disease Management
Market Dynamics
Patient Monitoring Overview
Key Factors in Patient Compliance
Market Drivers
Shifting Patient Demographics
Industry Alignment
and Competitive Landscape
Self-Monitoring
Technology Strategies
Needle-Stick Tests
Dry Chemistry Test Strips
Cassettes
Meters
Self-Collected / Mail-in Tests
Combination Meters
Continuous Monitors
Future Developments
Noninvasive Monitors
Technologies
Optical
Energy-based
Thermal
Signal Processing
Advances
Monitor Product Design & Patient
Issues
Reliability
Measurement Frequency
Patient/User Interface
Ease-of-Use
Data
Collection/Data Display
Continuous vs Discrete
Monitoring
Measurement Electronics
Calibration
Accuracy/Precision
Sensitivity
Sensor
Technology
Self-Monitoring Therapeutic
Segments
Atherosclerosis/Heart Disease
(Cholesterol)
Total Cholesterol
Triclycerides
Cholesterol Panel/Lipid Profile
Diabetes
(Glucose)
OTC Meters
Alternate Site Testing
Continuous Monitoring
Heart Valve
Replacement/Thrombosis
Oral Anticoagulation
Therapy
Prothrombin Time
Hypertension (Blood
Pressure)
Oscillometric Measurements
Demographic Trends
Self-Monitoring Product
Segment Analysis
Cholesterol Monitors
FDA
Approved Products
Products in Development
Coagulation Monitoring
FDA Approved Products
Products in Development
Glucose Monitors
Traditional Meters
Needle-stick
Alternate Site
Testing
Continuous Monitors
FDA-Approved
Monitors
Development-stage Monitors
Noninvasive Glucose Monitors
Combination Monitors
Product Design Factors
FDA Approved Products
Hypertension
Existing Products
Emerging
Technologies
Potential/Emerging Self-Monitoring
Segments
Market Factors
Clinical Trial
Issues
Regulations and Guidance
Managed
care/Reimbursement
Patient Compliance
Marketing & Distribution
Sourcing/Private
Labeling
Patient Self-Monitoring - Company
Profile
|
|
|
|
|
